{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:21:21Z","timestamp":1771248081733,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-152-01\/503-11-001"],"award-info":[{"award-number":["503\/1-152-01\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. In recent decades, an increasing incidence of BP has been reported. The rationale for this study arises from the limited availability of advanced immunopathological and serological assays for assessing disease activity in bullous pemphigoid across many clinical centers. This systematic review evaluates evidence regarding hematological markers derived from complete blood count (CBC), such as eosinophil count and neutrophil-to-lymphocyte ratio (NLR), in BP patients. The Ovid MEDLINE and EMBASE databases were searched for English-language peer-reviewed papers published until 2 May 2025. Sixteen studies involving 1775 patients were included. Eosinophil count consistently correlated with disease severity, clinical phenotype, treatment response, and relapse risk, while NLR showed potential as a prognostic and therapeutic marker. Given their accessibility and cost-effectiveness, these parameters may have practical value in the routine clinical management of BP.<\/jats:p>","DOI":"10.3390\/ijms27010340","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:25:51Z","timestamp":1766989551000},"page":"340","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Accessible Hematological Markers in Bullous Pemphigoid: A Systematic Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0645-7824","authenticated-orcid":false,"given":"Aleksandra","family":"Ma\u0142olepsza","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1319-9779","authenticated-orcid":false,"given":"Katarzyna","family":"Juczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-960X","authenticated-orcid":false,"given":"Anna","family":"Wo\u017aniacka","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Brzeszczy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of General Biochemistry, University of Lodz, 90-236 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-3080","authenticated-orcid":false,"given":"Agnieszka","family":"\u017bebrowska","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous Pemphigoid: From the Clinic to the Bench","volume":"30","author":"Zambruno","year":"2012","journal-title":"Clin. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous Pemphigoid: A Systematic Review","volume":"78","author":"Lamberts","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","article-title":"Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany","volume":"136","author":"Recke","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kridin, K., and Ludwig, R.J. (2018). The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00220"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of Disease: Pemphigus and Bullous Pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu. Rev. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K Guidelines for the Management of Bullous Pemphigoid Initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/bjd.19611","article-title":"International Validation of the Bullous Pemphigoid Disease Area Index Severity Score and Calculation of Cut-off Values for Defining Mild, Moderate and Severe Types of Bullous Pemphigoid","volume":"184","author":"Masmoudi","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1590\/abd1806-4841.20164935","article-title":"Quality of Life, Depression, Anxiety and Loneliness in Patients with Bullous Pemphigoid. A Case Control Study","volume":"91","author":"Kouris","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2024.3425","article-title":"Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis","volume":"160","author":"Chou","year":"2024","journal-title":"JAMA Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10238-018-0538-x","article-title":"Associations between the Neutrophil-to-Lymphocyte and the Platelet-to-Lymphocyte Ratios and the Presence and Severity of Psoriasis: A Systematic Review and Meta-Analysis","volume":"19","author":"Paliogiannis","year":"2019","journal-title":"Clin. Exp. Med."},{"key":"ref_11","first-page":"11026","article-title":"Neutrophil-Lymphocyte Ratio in Systemic Lupus Erythematosus Disease: A Retrospective Study","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref_14","first-page":"16","article-title":"Eosinophil and Monocyte Counts as Hematological Markers for Response to Tetracyclines for Treating Bullous Pemphigoid","volume":"18","author":"Akarsu","year":"2024","journal-title":"Turk. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/ijpm.ijpm_410_21","article-title":"Role of Neutrophil-to-Lymphocyte, Neutrophil-to-Eosinophil and Platelet-to-Lymphocyte Ratios in the Diagnosis of Bullous Pemphigoid and Pemphigus Disease","volume":"66","author":"Rai","year":"2023","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_16","first-page":"80","article-title":"Alterations in Inflammation Markers Due to Disease Activation in Autoimmune Bullous Diseases","volume":"31","author":"Sahin","year":"2023","journal-title":"Acta Dermatovenerol. Croat. ADC"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.2340\/actadv.v102.2938","article-title":"Skin Eosinophil Counts in Bullous Pemphigoid as a Prognostic Factor for Disease Severity and Treatment Response","volume":"103","author":"Baum","year":"2023","journal-title":"Acta Derm. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00403-023-02639-w","article-title":"Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Positively Correlated with Disease Activity of Bullous Pemphigoid","volume":"315","author":"Sun","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ad.2022.05.021","article-title":"Association of Peripheral Blood and Cutaneous Eosinophils With Bullous Pemphigoid Disease Severity and Treatment Outcomes","volume":"113","author":"Garrido","year":"2022","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_20","first-page":"e236","article-title":"Tissue Eosinophil Levels as a Marker of Disease Severity in Bullous Pemphigoid","volume":"62","author":"Cin","year":"2021","journal-title":"Australas. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e13958","DOI":"10.1111\/dth.13958","article-title":"Total IgE, Eosinophils, and Interleukins 16, 17A, and 23 Correlations in Severe Bullous Pemphigoid and Treatment Implications","volume":"33","author":"Delli","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijwd.2020.01.005","article-title":"Correlation of Dermal and Blood Eosinophilia with Bullous Pemphigoid Disease Severity","volume":"6","author":"Farnaghi","year":"2020","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e13790","DOI":"10.1111\/dth.13790","article-title":"Dipeptidyl-Peptidase IV Inhibitors (DPP4i)-Associated Bullous Pemphigoid: Estimating the Clinical Profile and Exploring Intraclass Differences","volume":"33","author":"Kridin","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/bjd.16679","article-title":"Peripheral Eosinophilia in Bullous Pemphigoid: Prevalence and Influence on the Clinical Manifestation","volume":"179","author":"Kridin","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5021\/ad.2018.30.5.544","article-title":"Circulating Eosinophil and Neutrophil Counts Correlate with Disease Severity in Bullous Pemphigoid","volume":"30","author":"Park","year":"2018","journal-title":"Ann. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity","volume":"153","author":"Huebner","year":"2017","journal-title":"JAMA Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/jdv.12995","article-title":"Neurological Disorders in Patients with Bullous Pemphigoid: Clinical and Experimental Investigations","volume":"29","author":"Gambichler","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Messingham, K.N., Holahan, H.M., Frydman, A.S., Fullenkamp, C., Srikantha, R., and Fairley, J.A. (2014). Human Eosinophils Express the High Affinity IgE Receptor, Fc\u03b5RI, in Bullous Pemphigoid. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107725"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamadermatol.2018.4556","article-title":"Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/12034754241266171","article-title":"Serum Biomarkers in Bullous Pemphigoid: A Systematic Review","volume":"28","author":"Geng","year":"2024","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0190-9622(87)80227-X","article-title":"Blood Eosinophilia as a Severity Marker for Bullous Pemphigoid","volume":"16","author":"Bernard","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(83)70073-3","article-title":"Bullous Pemphigoid: A Cause of Peripheral Blood Eosinophilia","volume":"8","author":"Bushkell","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hung, C.-T., Chang, Y.-L., and Wang, W.-M. (2022). Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: Clinical, Laboratory, and Histological Features, and Possible Pathogenesis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214101"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2013-02-487470","article-title":"Implications of DPP4 Modification of Proteins That Regulate Stem\/Progenitor and More Mature Cell Types","volume":"122","author":"Ou","year":"2013","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/1346-8138.15778","article-title":"Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: A Comparative Study of 100 Patients with Bullous Pemphigoid and Diabetes Mellitus","volume":"48","author":"Chanprapaph","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/1346-8138.16394","article-title":"Clinical Features of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in Japan: A Nationwide Retrospective Observational Study","volume":"49","author":"Sugiyama","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl Peptidase IV Inhibitors, a Risk Factor for Bullous Pemphigoid: Retrospective Multicenter Case-Control Study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjd.14601","article-title":"French Association of Regional PharmacoVigilance Centres Bullous Pemphigoid and Dipeptidyl Peptidase IV Inhibitors: A Case-Noncase Study in the French Pharmacovigilance Database","volume":"175","author":"Moulis","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_40","first-page":"88","article-title":"Clinical, Demographical Features, Accompanying Diseases and Neutrophil to Lymphocyte Ratioplatelet to Lymphocyte Ratio in Patients with Bullous Pemphigoid","volume":"41","author":"Parlak","year":"2019","journal-title":"Cumhur. Med. J."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Andersen, C.S.B., Kvist-Hansen, A., Siewertsen, M., Enevold, C., Hansen, P.R., Kaur-Knudsen, D., Zachariae, C., Nielsen, C.H., Loft, N., and Skov, L. (2023). Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076111"},{"key":"ref_42","first-page":"e43790","article-title":"The Relationship of Hematological Parameters and C-Reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis","volume":"15","author":"Karaman","year":"2023","journal-title":"Cureus"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.5826\/dpc.1501a4969","article-title":"Evaluation of the Effects of Systemic Therapy on Inflammatory Markers and Disease Severity in Patients with Pemphigus","volume":"15","year":"2025","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e22850","DOI":"10.1097\/MD.0000000000022850","article-title":"Clinical Characteristics, Mortality, and Prognostic Factors for Bullous Pemphigoid in a Thai Population","volume":"99","author":"Amonchaisakda","year":"2020","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean Platelet Volume: A Link between Thrombosis and Inflammation?","volume":"17","author":"Gasparyan","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/09537104.2013.784735","article-title":"Mean Platelet Volume and Eosinophilia Relationship in Patients with Bullous Pemphigoid","volume":"25","author":"Rifaioglu","year":"2014","journal-title":"Platelets"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:37:34Z","timestamp":1771245454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/1\/340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27010340"],"URL":"https:\/\/doi.org\/10.3390\/ijms27010340","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}